The LifeMD (LFMD)-Medifast (MED) partnership provides LifeMD patients access to Medifast’s Optavia medically-supported weight loss program. Dan Chard, Medifast CEO and Justin Schreiber, LifeMD CEO discuss this partnership and medically-supported weight loss. This partnership is supported by Medifast’s $20M investment into LifeMD, including a $10M payment and $10M direct equity investment. It gives patients the personalized 1-on-1 care they need while offering scalability needed to meet growing demand. They then go over what investors should know about medically-supported weight loss. Tune in to find out more about the stock market today.
Trading 360
04 Jan 2024
SHARE
Market On Close
06 Mar 2024
Market On Close
28 Mar 2024
The Watch List
02 Feb 2024
The Watch List
05 Mar 2024
Morning Trade Live
07 Mar 2024
Morning Trade Live
29 Feb 2024